Skip to main content

Tahl Cindy

See Remarks | General Counsel And Secretary

1 company

Insider Signal Score

79
Excellent
Trades Analyzed
14
12M Win Rate
91.7%
Avg 3M Return
-1.4%
Avg 12M Return
+58.5%

Tahl Cindy is a See Remarks at FATE THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 45 sells.

Estimated insider holdings value: $1.0M based on current market prices.

Holdings by Company

FATEJan 15, 2026
Current Shares487.1K
Value$1.02M
Net Activity-599,235
Bought: 0Sold: 599.2K

Transaction History

Showing 10 filings (page 2)
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Jan 3, 2022
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE50,000$59.34$2,966,852.75-6.2%-29.7%-83.1%
Oct 1, 2021
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE50,000$58.83$2,941,461.99-11.9%+1.0%-62.3%
Jul 1, 2021
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE55,534$85.24$4,733,743.28-3.1%-36.6%-73.3%
Apr 1, 2021
FATE
Fate Therapeutics Inc
See RemarksSale+OE30,000$83.81$2,514,329.03-3.0%+6.0%-49.6%
Jan 19, 2021
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE35,000$114.76$4,016,639.28-8.4%--
Jan 11, 2021
FATE
Fate Therapeutics Inc
General Counsel And SecretarySell9,483$114.94$1,090,021.13-1.4%--
Nov 5, 2020
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE70,801$50.47$3,573,391.76-19.0%--
Oct 16, 2020
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE29,199$50.25$1,467,211.79-22.7%--
Oct 1, 2020
FATE
Fate Therapeutics Inc
General Counsel And SecretarySale+OE35,000$40.74$1,426,065.22-9.9%--
Jan 8, 2020
FATE
Fate Therapeutics Inc
General Counsel And SecretarySell5,700$20.72$118,085.19-5.4%--